Journal
ONCOLOGY RESEARCH
Volume 27, Issue 6, Pages 629-634Publisher
COGNIZANT COMMUNICATION CORP
DOI: 10.3727/096504018X15228018559434
Keywords
Kaempferol; Cell proliferation; Cell cycle; Apoptosis; DNA damage; Breast cancer (BC)
Categories
Ask authors/readers for more resources
Kaempferol is a flavonoid that has been extensively investigated owing to its antitumor effects. Nevertheless, little is known about its underlying mechanisms of action. We aimed to explore the role of kaempferol in breast cancer (BC), and thus we investigated how kaempferol suppresses the growth of BC cells. The cells were treated with kaempferol, and the effects on multiple cancer-associated pathways were evaluated. The MTS assay was used to study the cell growth inhibition induced by kaempferol. The cell cycle was analyzed by flow cytometry. Western blotting was used to analyze cellular apoptosis and DNA damage. We found that the proliferation of the triple-negative BC (TNBC) MDA-MB-231 cells was suppressed effectively by kaempferol. Interestingly, the suppressive effect of kaempferol on cell proliferation was stronger in MDA-MB-231 cells than in the estrogen receptor-positive BT474 cell line. Furthermore, after the treatment with kaempferol for 48 h, the population of cells in the G(1) phase was significantly reduced, from 85.48% to 51.35%, and the population of cells in the G(2) phase increased markedly from 9.27% to 37.5%, which indicated that kaempferol contributed to the induction of G(2)/M arrest. Kaempferol also induced apoptosis and DNA damage in MDA-MB-231 cells. Kaempferol increased the expression levels of gamma H2AX, cleaved caspase 9, cleaved caspase 3, and p-ATM compared to those of the control group. Collectively, these results showed that kaempferol may be a potential drug for the effective treatment of TNBC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available